Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial

Original Article

J. Lv, L. Liu, W. Wang, X. Wang, Q. Zuraw, V. Perkovic, J. Fang, and H. Zhang

N Engl J Med 2026;394:1916-1924

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
05/13/2026
Course expires: 
05/14/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.